Overexpression of MiR-146a-5p Upregulates lncRNA HOTAIR in Triple-Negative Breast Cancer Cells and Predicts Poor Prognosis

被引:26
|
作者
Liang, Hongguang [1 ]
Huang, Weihua [1 ]
Wang, Yuandong [1 ]
Ding, Lingying [2 ]
Zeng, Lixian [2 ]
机构
[1] Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Integrated Hosp Tradit Chinese Med, 13 Liugang Rd, Guangzhou 510315, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
triple-negative breast cancer; miR-146a-5p; lncRNA HOTAIR; prognosis; cancer cell migration; FEATURES;
D O I
10.1177/1533033819882949
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MiR-146a-5p plays different roles in different types of cancers. We showed that miR-146a-5p and long noncoding RNA HOTAIR were both upregulated in triple-negative breast cancer. Follow-up study showed that high levels of miR-146a-5p and HOTAIR in tumor tissues were closely correlated with poor survival. MiR-146a-5p and HOTAIR were positively correlated in tumor tissues. MiR-146a-5p positively regulated HOTAIR triple-negative breast cancer cells, while HOTAIR showed no regulatory effects on miR-146a-5p expression. MiR-146a-5p and HOTAIR positively regulated the migration and invasion of triple-negative breast cancer cells. In addition, HOTAIR silencing attenuated the effects of miR-146a-5p. Therefore, overexpression of miR-146a-5p may promote triple-negative breast cancer cell invasion and migration by upregulating HOTAIR.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5
    Si, Chengshuai
    Yu, Qiao
    Yao, Yufeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (05) : 4515 - 4521
  • [2] lncRNA LINC000466 Predicts the Prognosis and Promotes the Progression of Triple-negative Breast Cancer via Modulating miR-539-5p
    Liu, Jiaqi
    Yu, Heshan
    Cui, Haiyun
    Wei, Feifei
    Yan, Ting
    Li, Tong
    Liu, Yanze
    Chu, Jun
    CLINICAL BREAST CANCER, 2022, 22 (04) : 374 - 380
  • [3] lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p
    Peng, Yi
    Huang, Xiaoxi
    Wang, Hongmei
    BMC MOLECULAR AND CELL BIOLOGY, 2022, 23 (01)
  • [4] lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p
    Yi Peng
    Xiaoxi Huang
    Hongmei Wang
    BMC Molecular and Cell Biology, 23
  • [5] A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Ma, Fei
    Ding, Xiaoyan
    Fan, Ying
    Ying, Jianming
    Zheng, Shan
    Lu, Ning
    Xu, Binghe
    PLOS ONE, 2014, 9 (11):
  • [6] Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer
    Panoutsopoulou, Konstantina
    Liu, Yueyang
    Avgeris, Margaritis
    Dreyer, Tobias
    Dorn, Julia
    Magdolen, Viktor
    Scorilas, Andreas
    CLINICAL BIOCHEMISTRY, 2023, 114 : 43 - 51
  • [7] Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
    Ohi, Yasuyo
    Umekita, Yoshihisa
    Yoshioka, Takako
    Souda, Masakazu
    Rai, Yoshiaki
    Sagara, Yoshiaki
    Sagara, Yasuaki
    Sagara, Yoshiatsu
    Tanimoto, Akihide
    HISTOPATHOLOGY, 2011, 59 (04) : 776 - 780
  • [8] Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer
    Yang, Qiuhui
    Fu, Yeqin
    Wang, Jiaxuan
    Yang, Hongjian
    Zhang, Xiping
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (12): : 1123 - 1140
  • [9] Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer
    Hong Yu
    Hui Li
    Hua Qian
    Xia Jiao
    Xiaowei Zhu
    Xiaoqin Jiang
    Guihong Dai
    Junxing Huang
    Medical Oncology, 2014, 31
  • [10] Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer
    Yu, Hong
    Li, Hui
    Qian, Hua
    Jiao, Xia
    Zhu, Xiaowei
    Jiang, Xiaoqin
    Dai, Guihong
    Huang, Junxing
    MEDICAL ONCOLOGY, 2014, 31 (11) : 1 - 6